Definitions Flashcards
Organisation
Reorganising a tissue, the growth of capillaries and fibroblasts to change it from one thing to another, typically filling a cavity
Resolution
When the initiating factor is removed and the tissue is undamaged or able to regenerate
Repair
When the initiating factor is still present, the tissue is damaged and unable to regenerate
Healing by 1st intention
There is no gap between skin edges, the skin heals straight away and there is no infection
Healing by 2nd intention
There is a loss of tissue, you get granulation before a big scar forms
Stasis
A period of inactivity
An embolus
A mass of material in the vascular system. It can be lodged in a vessel and block it
Ischaemia
Lack of blood and reduction in blood flow
Infarction
When the cells have died from reduced blood flow
End artery supply
When only one artery supplies an organ
Congenital disorder
Disorders present at birth, could be developed in utero or inherited
Inherited disorder
Disorders caused by inherited genetic abnormality
Acquired disorders
Disorders caused by non-genetic environmental factors, they can be congenital (feral alcohol syndrome)
Hypertrophy
Increase in size of tissue caused by an increase in size of constituent cells
Hyperplasia
Increase in size of tissue caused by an increase in number of constituent cells
Atrophy
Decrease in size of tissue caused by a decrease in number or size of constituent cells
Metaplasia
Change in differentiation of a cell from one fully-differentiated type to a different fully-differentiated type
Dysplasia
Imprecise term for the morphological changes seen in cells in the progression to becoming cancer
Dermal elastosis
Wrinkles
Carcinoma in situ
A neoplasm that hasn’t broken through the basement membrane
Invasive carcinoma
A neoplasm that has broken through the basement membrane
Micro-invasive carcinoma
A neoplasm that has partly broken through the basement membrane
Tumour
Any abnormal swelling, including a neoplasm, inflammation, hyper trophy and hyperplasia
Neoplasm
A lesion resulting from the autonomous abnormal growth of cells, which persists after the initiating stimulus is removed. A new growth.
Screening
The process of identifying apparently healthy people who may be at an increased risk of a disease or condition
Sensitivity
How successful was the test at identifying all those with cancer in the group studied
Specificity
How well did the test identify all those without cancer in the group studied
Clonal selection hypothesis
The body that produces lots and lots of different types of B cells and it’s just luck that they fit with the bacteria
Primary lymphoid tissue
Where lymphocytes reach maturity (bone marrow/thymus). Also known as central lymphoid tissue
Secondary lymphoid tissue
Where lymphocytes are activated by antigens (spleen/lymph nodes). Also know as peripheral lymphoid tissue
Antimicrobial peptide
Secreted PRR that binds to the outside of a pathogen to make it easier for phagocytes to find
Lectins and collectins
Carbohydrate-containing proteins (secreted PRR) that bind to microbe walls, activate complement and improve phagocytosis by making the cell more obvious
Toll-like receptor
Cell associated (on the cell surface) PRR that binds to lipopolysaccharides and signals an immune response
Mannose receptor
Cell-associated PRR present on macrophages that detect fungi
Dectin-1
Cell associated PRR receptor present on phagocytes that detects fungi, it is more widespread that mannose receptor because it is on more cells
Nod-like receptor
Intracellular PRR that detects intracellular microbial pathogens
Hypersensitivity reaction
When an altered state of immunological responsiveness causes an inappropriate or excessive immune response
Rig-like receptor
Intracellular PRR that detects intracellular double-stranded viral RNA and DNA
PRR
Pathogen recognition receptor
PAMP
Pathogen associated molecular patterns
Natural killer cells
A lymphocyte (not phagocytic) that recognises ‘altered self’, kills unless they recognise a self-protein
Defensins
Positively charged peptides made by neutrophils. Insert into bacterial membranes and cause apoptosis of bacteria
Interferons
Produced by virally infected cells and T helper 1 cells. Combat viruses by interfering with cell replication and activated other immune responses
Cytokine
Small molecules secreted during an immune response that helps to signal and activate responding cells
Chemokines
Small molecules secreted during an immune response, these often signal cells to migrate to areas of inflammation
Perforin
Aids in delivering contents of cytotoxic T cell granules into the cytoplasm of target cell
Granzymes
Granules in cytotoxic T cells that are serine proteases, which activate apoptosis once in the cytoplasm of target cell
Granulysin
Granule in cytotoxic T cell that has anti-microbial actions and can induce apoptosis of target cell
Treg cells
T cells which can negatively regulate immune responses. High Treg count has bad patient prognosis
Natural Treg cells
Derived in the thymus, have CD4CD25 receptors
Adaptive Treg cells
Conventional T cells that are induced to turn into Treg cells in the periphery
Human leukocyte antigen
A group of proteins encoded within the MHC that the body uses to identify ‘self’
Cancer immunosurveillance
When the immune system can recognise and destroy nascent transformed cells all the time, normal control
Cancer immunoediting
Tumours tend to be genetically unstable, thus the immune system can kill and also induce changes in the tumour resulting in tumour escape and recurrence
Tumour escape
Immune responses change tumours such that the tumours will no longer be seen by the immune system
Tumour evasion
Tumours change the immune response by promoting immune suppressor cells
Immunotherapy
Learning how to harness the immune system to kill tumours
Adaptive immunotherapy
Inducing an immune response against the tumour that would discriminate between the tumour and normal cells
Active immunotherapy
Augmentation of host immunity to tumours with cytokines and co-stimulators or vaccinations
Passive immunotherapy
Adaptive cellular therapy (T cells) or anti-tumour antibodies
Allergy
Abnormal response to harmless foreign material
Atopy
A tendency to develop allergies
Tumour necrosis factor
Proinflammatory Cytokine with many functions, it causes death, mediates inflammation, maturation of dendritic cells, activation of T helper 1 cells
IL-6
An inflammatory cytokine, to function naked IL-6 requires gp130 and IL-6 receptor to be displayed on a cell
Pharmacokinetics
Describes how the body affects the drug
Pharmacodynamics
Describes how the drug affects the body
Potency
How well the drug works, described in EC50 (concentration that gives maximal response)
Full agonist
An agonist that gives maximal response
Partial agonist
An agonist that will never give you the full response. The Emax value describes the maximal response
Competitive agonist
Occurs when it can give maximal response is given by both the agonist and the antagonist
Non-competitive antagonist
When the maximal response of the agonist is reduced